These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24124)

  • 1. Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells.
    Hackstadt T; Mallavia LP
    J Virol; 1978 Feb; 25(2):510-7. PubMed ID: 24124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.
    Cheng YC; Tsou TY; Hackstadt T; Mallavia LP
    J Virol; 1979 Jul; 31(1):172-7. PubMed ID: 228052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.
    Shigeta S; Mori S; Yokota T; Konno K; De Clercq E
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1053-8. PubMed ID: 3015014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus thymidine kinase. Characterization and substrate specificity.
    Roberts GB; Fyfe JA; McKee SA; Rahim SG; Daluge SM; Almond MR; Rideout JL; Koszalka GW; Krenitsky TA
    Biochem Pharmacol; 1993 Dec; 46(12):2209-18. PubMed ID: 8274154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of deoxypyrimidine kinase activity in human embryonic lung cells infected with varicella-zoster virus.
    Ogino T; Otsuka T; Takahashi M
    J Virol; 1977 Mar; 21(3):1232-5. PubMed ID: 191646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus specified deoxypyrimidine kinase and the uptake of exogenous nucleosides by infected cells.
    Jamieson AT; Subak-Shape JH
    J Gen Virol; 1976 Jun; 31(3):303-14. PubMed ID: 180246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
    Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript.
    Sawyer MH; Ostrove JM; Felser JM; Straus SE
    Virology; 1986 Feb; 149(1):1-9. PubMed ID: 3004022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.
    Abele G; Karlström A; Harmenberg J; Shigeta S; Larsson A; Lindborg B; Wahren B
    Antimicrob Agents Chemother; 1987 Jan; 31(1):76-80. PubMed ID: 3032092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum antibodies to varicella-zoster virus thymidine kinase.
    Källander CF; Gronowitz JS; Torfason EG
    Infect Immun; 1982 Apr; 36(1):30-7. PubMed ID: 6176544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.
    Roberts GB; Fyfe JA; Gaillard RK; Short SA
    J Virol; 1991 Dec; 65(12):6407-13. PubMed ID: 1658351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):7-10. PubMed ID: 3022711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of varicella zoster virus thymidine kinase.
    Bird LE; Ren J; Wright A; Leslie KD; Degrève B; Balzarini J; Stammers DK
    J Biol Chem; 2003 Jul; 278(27):24680-7. PubMed ID: 12686543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
    Suzutani T; Davies LC; Honess RW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virus.
    Fyfe JA; Biron KK; McKee SA; Kelly CM; Elion GB; Soike KF
    Am J Med; 1982 Jul; 73(1A):58-61. PubMed ID: 6285734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to anti-herpesvirus nucleosides.
    Suzutani T; Ogasawara M; Shibaki T; Azuma M
    Antiviral Res; 2000 Jan; 45(1):79-82. PubMed ID: 10774592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.